EMD Biosciences, Inc. Releases New Web-Based Signal Transduction Interactive Pathways
10/19/2005 5:11:49 PM
EMD Biosciences, Inc. (EMD), a major supplier of premium tools for proteomics and disease pathway analysis known through its global brands Calbiochem(R), Novabiochem(R), and Novagen(R), today announced the release of several new Signal Transduction Interactive Pathways on its website. EMD is part of the Life Science and Analytics (LSA) division of Merck KGaA (Darmstadt, Germany) and operates as EMD Biosciences, Inc. in North America and as Merck Biosciences outside North America.
comments powered by